Back to Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 2

Risk factors of allergic rhinitis: genetic or environmental?

Authors De-Yun Wang

Published 15 July 2005 Volume 2005:1(2) Pages 115—123

De-Yun Wang

Department of Otolaryngology, Faculty of Medicine, National University of Singapore, Singapore

Abstract: Allergic diseases such as allergic rhinitis represent a global health problem, affecting 10%–25% of the world population. There is clear evidence to support the concept that allergic diseases are influenced by genetic predisposition and environmental exposure. Polymorphisms of candidate genes have been associated with clinical expression of these diseases. However, characterization of these susceptibility markers in discriminating an “allergic individual” from the general population has not yet been achieved, and the value of how this genetic insight leading to recognition of specific subtypes of these disorders still needs to be confirmed. Environmental factors (eg, air pollution and bacterial/viral infection) also play an important role in the development of the diseases. A number of epidemiologic studies have supported the “hygiene hypothesis”, which is based on the observations that Th1 responses induced by microbial stimulation can counterbalance allergen-induced Th2 responses. Future studies are needed to identify the key genes or their haplotypes for atopic phenotypes and to investigate the interactions between genetic and environmental factors that influence the complex trait of allergic diseases. This will help us to further understand the etiology of the diseases and develop new avenues for genetically oriented diagnosis and more effective measures of prevention and intervention.

Keywords: allergic rhinitis, genetic predisposition, environmental factors

Download Article [PDF] 

Readers of this article also read:

Rotator cuff troublemakers: pitfalls of MRI and ultrasound

Christina M Chingkoe, Jeremy H White, Luck J Louis, et al

Open Access Journal of Sports Medicine 2010, 1:1-9

Published Date: 22 December 2009

Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese

Xiao Hui Liang, Wai Cheung, Chew Kiat Heng, De-Yun Wang

Therapeutics and Clinical Risk Management 2005, 1:243-246

Published Date: 15 October 2005

A review of studies of adherence with antihypertensive drugs using prescription databases

Nicola Fitz-Simon, Kathleen Bennett, John Feely

Therapeutics and Clinical Risk Management 2005, 1:93-106

Published Date: 15 July 2005

Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy

Charity D Scripture, William D Figg, Alex Sparreboom

Therapeutics and Clinical Risk Management 2005, 1:107-114

Published Date: 15 July 2005

Clinical implications of changes in hepatic drug metabolism in older people

Sarah N Hilmer, Gillian M Shenfield, David G Le Couteur

Therapeutics and Clinical Risk Management 2005, 1:151-156

Published Date: 15 July 2005

The controversy surrounding OxyContin abuse: issues and solutions

Sujata S Jayawant, Rajesh Balkrishnan

Therapeutics and Clinical Risk Management 2005, 1:77-82

Published Date: 15 July 2005